Guardian Cash from 2010 to 2024
| GRDN Stock | 24.94 0.02 0.08% |
Cash | First Reported 2010-12-31 | Previous Quarter 752 K | Current Value 714.4 K | Quarterly Volatility 3.5 M |
Check Guardian Pharmacy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardian Pharmacy's main balance sheet or income statement drivers, such as Interest Expense of 2.4 M, Selling General Administrative of 147.1 M or Total Revenue of 957.9 M, as well as many indicators such as . Guardian financial statements analysis is a perfect complement when working with Guardian Pharmacy Valuation or Volatility modules.
Guardian | Cash |
Latest Guardian Pharmacy's Cash Growth Pattern
Below is the plot of the Cash of Guardian Pharmacy Services, over the last few years. Cash refers to the most liquid asset of Guardian Pharmacy, which is listed under current asset account on Guardian Pharmacy Services, balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Guardian Pharmacy customers. The amounts must be unrestricted with restricted cash listed in a different Guardian Pharmacy account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Guardian Pharmacy's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardian Pharmacy's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Guardian Cash Regression Statistics
| Arithmetic Mean | 5,868,293 | |
| Geometric Mean | 4,361,275 | |
| Coefficient Of Variation | 58.98 | |
| Mean Deviation | 2,070,864 | |
| Median | 6,449,000 | |
| Standard Deviation | 3,461,390 | |
| Sample Variance | 12T | |
| Range | 14.4M | |
| R-Value | (0.32) | |
| Mean Square Error | 11.6T | |
| R-Squared | 0.10 | |
| Significance | 0.25 | |
| Slope | (247,436) | |
| Total Sum of Squares | 167.7T |
Guardian Cash History
Other Fundumenentals of Guardian Pharmacy
Guardian Pharmacy Cash component correlations
About Guardian Pharmacy Financial Statements
Guardian Pharmacy investors utilize fundamental indicators, such as Cash, to predict how Guardian Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash | 752 K | 714.4 K | |
| Change In Cash | 145 K | 95.4 K | |
| Free Cash Flow | 56.3 M | 49.9 M | |
| Begin Period Cash Flow | 607 K | 576.6 K | |
| Other Non Cash Items | 283 K | 264.4 K | |
| Total Cash From Operating Activities | 70.8 M | 63.4 M | |
| Total Cash From Financing Activities | -57.2 M | -60.1 M | |
| End Period Cash Flow | 752 K | 714.4 K |
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving together with Guardian Stock
Moving against Guardian Stock
| 0.71 | CCM | Concord Medical Services | PairCorr |
| 0.42 | AMS | American Shared Hospital | PairCorr |
| 0.4 | NIVF | NewGenIvf Group | PairCorr |
| 0.31 | TOI | Oncology Institute | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services, to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Guardian Pharmacy Correlation against competitors. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.